SERP
Comments:
Several proteins are down-regulated in the proteomics analysis. It is therefore unclear how selective the PROTAC is. Running proteomics at an earlier timepoint and/or lower compound concentration may provide improved clarity on this. From the current data, it appears non-selective.
Due to the questions around in vitro selectivity, I would expect more data to be obtained before this is used as a chemical probe in vivo. There is also no in-vivo efficacy data or modelling shown for doses <5mg/k in the paper and thus it's unclear whether the doses of 1 and 2mg/kg would have the appropriate pharmacological effect.
(last updated:
12 Aug 2025 )